ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in ProMIS Neurosciences Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q2 2023
- Shares held
- 2.81M
- +2.62M (+1,403.5%) vs. Q2 2023
- Total value
- $5.61M
- +$4.89M (+675.1%) vs. Q2 2023
- New holders
- 3
- 1 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 103 | $204 | 0.00% | −601−85.4% | Reduced |
| AllSquare Wealth Management LLC | 185 | $366 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 149 | $391 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 333 | $633 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 388 | $780 | 0.00% | −4,508−92.1% | Reduced |
| Royal Bank of Canada | 713 | $1.00K | 0.00% | −1,780−71.4% | Reduced |
| Bank of America Corp | 1,666 | $3.30K | 0.00% | −11,850−87.7% | Reduced |
| Claret Asset Management Corp | 10,830 | $22.0K | 0.00% | −1,500−12.2% | Reduced |
| Fiduciary Trust Co | 20,008 | $39.6K | 0.00% | +9,850+97.0% | Added |
| Ieq Capital, LLC | 39,191 | $77.6K | 0.00% | 00.0% | Unchanged |
| Northeast Financial Consultants Inc | 100,000 | $198.0K | 0.01% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 265,958 | $526.7K | 0.17% | +265,958 | New |
| Ally Bridge Group (NY) LLC | 531,915 | $1.05M | 1.24% | +531,915 | New |
| Sphera Funds Management Ltd. | 1,834,042 | $3.69M | 0.88% | +1,834,042 | New |
| Morgan Stanley | 0 | $0 | 0.00% | −1,808−100.0% | Sold out |
| Gables Capital Management Inc. | 0 | $0 | 0.00% | −833−100.0% | Sold out |